Helen Dwight serves as Senior Director of Health Policy at The Picard Group.

With over 15 years of experience in Washington, D.C., she is a seasoned governmental affairs leader who has navigated the ever-changing dynamics of the private and public sectors, turning complex policy and political challenges into actionable strategy. 

​

Prior to joining The Picard Group, Dwight spent seven years in the pharmaceutical industry, most recently leading the federal affairs team for Otsuka America Pharmaceutical. During her tenure, she represented Otsuka’s interests with Congress, the Administration, trade associations, and third-party coalitions, developing and executing strategies to ensure continued patient access to mental health therapeutics. Prior to Otsuka, Dwight spent several years at AstraZeneca, where she drove advocacy efforts on issues from hospital pricing strategy to the company’s COVID-19 vaccine response.

​

Dwight has collaborated across several cross-functional teams to execute engagement strategies to protect and defend the healthcare industry against harmful policies. She has also sought opportunities to strengthen the innovation pipeline for future therapeutic development. 

​

Dwight began her career on Capitol Hill, where she worked for nearly a decade for several Congressional offices on the House Committee on Energy and Commerce, shaping major legislation to combat the opioid crisis, championing rare disease issues, and drove reauthorization of the nation’s biodefense infrastructure and rapid response programs.

​

A native New Englander, Dwight is a graduate of Southern Methodist University in Dallas, TX and holds an MBA from UVA Darden School of Business. She resides in Washington, D.C.